Morning Walk covered by Health Insurance, new government policy boosts the rehabilitation robot market.
Curexo announced that it had supplied a total of 12 medical robots in the first quarter of 2022.
The number of units supplied in the first quarter of this year increased particularly compared to the first quarter of 2020 and the first quarter of 2021. Furthermore, seven out of twelve units are of great significance for overseas export.
According to Curexo, eight units of ‘Cubis-Joint,’ an artificial joint surgery robot, were supplied to domestic hospitals and seven units to India. And the gait rehabilitation robot ‘Morning Walk S200’ and the upper extremity rehabilitation robot ‘In Motion’ has been supplied with three units and one unit, respectively, to domestic rehabilitation hospitals.
A Curexo official declared, “The main factors for expanding the supply of medical robots in the first quarter of this year are the additional orders for ‘Cubis-Joint’ from India, the application of health insurance for domestic rehabilitation robots, and the expectation of market expansion for the new government’s rehabilitation robot policies.” “Thanks to these factors, the number of cases of artificial joint surgery with the Cubism Joint continues to increase in domestic and Indian hospitals, and clinical surgery with the demo robot has also produced satisfactory results, leading to additional supply contracts,” he added.
Curexo CS team employees are installing the gait rehabilitation robot 'Morning Walk S200' at a rehabilitation hospital.
Curexo CEO Jaejoon Lee said, “The medical robot business performance varies from quarter to quarter, but annual supply expansion and sales growth are noteworthy.” “Despite the aggravated global supply chain and the coronavirus, we expect to record positive sales results in the first quarter because we are confident of securing inventory, shortening the production period, and delivering quickly,” he counted. "In addition, we are promoting the excellence of Curexo medical robots by conducting continuous marketing through participation in medical device conferences held at home and abroad,” he expressed.
Meanwhile, Curexo's self-developed gait rehabilitation robot 'Morning Walk S200' started to be covered by health insurance from February 1 in accordance with a partial revision of the Ministry of Health and Welfare's 「Standards for Selection and Implementation of Selective Benefits」.
A Curexo representative stated, “We are already close to our domestic sales target of 6 units. We had set for selling three units of the Morning Walk S200 in the first quarter and one unit in the second quarter.” “We plan to raise our domestic sales target as we expect the sales increase with health insurance benefits, identified as the biggest obstacle, are resolved,” he declared.
